Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto SALVA/INSERISCI in fondo alla pagina
Purpose: The DIANA study aimed to evaluate how often antimicrobial de-escalation (ADE) of empirical treatment is performed in the intensive care unit (ICU) and to estimate the effect of ADE on clinical cure on day 7 following treatment initiation. Methods: Adult ICU patients receiving empirical antimicrobial therapy for bacterial infection were studied in a prospective observational study from October 2016 until May 2018. ADE was defined as (1) discontinuation of an antimicrobial in case of empirical combination therapy or (2) replacement of an antimicrobial with the intention to narrow the antimicrobial spectrum, within the first 3 days of therapy. Inverse probability (IP) weighting was used to account for time-varying confounding when estimating the effect of ADE on clinical cure. Results: Overall, 1495 patients from 152 ICUs in 28 countries were studied. Combination therapy was prescribed in 50%, and carbapenems were prescribed in 26% of patients. Empirical therapy underwent ADE, no change and change other than ADE within the first 3 days in 16%, 63% and 22%, respectively. Unadjusted mortality at day 28 was 15.8% in the ADE cohort and 19.4% in patients with no change [p = 0.27; RR 0.83 (95% CI 0.60–1.14)]. The IP-weighted relative risk estimate for clinical cure comparing ADE with no-ADE patients (no change or change other than ADE) was 1.37 (95% CI 1.14–1.64). Conclusion: ADE was infrequently applied in critically ill-infected patients. The observational effect estimate on clinical cure suggested no deleterious impact of ADE compared to no-ADE. However, residual confounding is likely.
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study / De Bus, L.; Depuydt, P.; Steen, J.; Dhaese, S.; De Smet, K.; Tabah, A.; Akova, M.; Cotta, M. O.; De Pascale, G.; Dimopoulos, G.; Fujitani, S.; Garnacho-Montero, J.; Leone, M.; Lipman, J.; Ostermann, M.; Paiva, J. -A.; Schouten, J.; Sjovall, F.; Timsit, J. -F.; Roberts, J. A.; Zahar, J. -R.; Zand, F.; Zirpe, K.; De Waele, J. J.; Rios, F.; Vazquez, A. R.; Vidal, M. G.; Zakalik, G.; Attokaran, A. G.; Banakh, I.; Dey-Chatterjee, S.; Ewan, J.; Ferrier, J.; Forbes, L.; Fourie, C.; Leditschke, A.; Murray, L.; Eller, P.; Biston, P.; Bracke, S.; De Crop, L.; De Schryver, N.; Frans, E.; Spapen, H.; Van Malderen, C.; Vansteelandt, S.; Vermeiren, D.; Arevalo, E. P.; Crespo, M.; Flores, R. Z.; Piza, P.; Tutillo, D. M.; Elme, A.; Kallaste, A.; Starkopf, J.; Bourenne, J.; Calypso, M.; Cohen, Y.; Dahyot-Fizelier, C.; Depret, F.; Guillot, M.; Imzi, N.; Jochmans, S.; Kouatchet, A.; Lepape, A.; Martin, O.; Heim, M.; Schaller, S. J.; Arvaniti, K.; Bekridelis, A.; Ioannidis, P.; Mitrakos, C.; Papanikolaou, M. N.; Pouriki, S.; Vemvetsou, A.; Abraham, B.; Bhattacharya, P. K.; Budugu, A.; Dixit, S.; Gurav, S.; Kandanuri, P.; Prabhu, D. A.; Rathod, D.; Savaru, K.; Udupa, A. N.; Varghese, S. B.; Bakhodaei, H. H.; Dabiri, G.; Fallahi, M. J.; Feiz, F.; Firoozifar, M.; Khaloo, V.; Maghsudi, B.; Masjedi, M.; Nikandish, R.; Sabetian, G.; Marsh, B.; Martin-Loeches, I.; Steiner, J.; Barbagallo, M.; Caricato, A.; Cortegiani, A.; D'Andrea, R.; Deana, C.; Donati, A.; Girardis, M.; Mandala, G.; Panarello, G.; Pasero, D.; Pelagalli, L.; Soave, P. M.; Spadaro, S.; Fujita, Y.; Fujiwara, S.; Hara, Y.; Hashi, H.; Hashimoto, S.; Hashimoto, H.; Hayakawa, K.; Inoue, M.; Isokawa, S.; Kameda, S.; Kamohara, H.; Kanamoto, M.; Katayama, S.; Kawagishi, T.; Kawano, Y.; Kida, Y.; Kita, M.; Kobayashi, A.; Kuriyama, A.; Naito, T.; Nashiki, H.; Nishiyama, K.; Shindo, S.; Suzuki, T.; Takaba, A.; Tanaka, C.; Tetsuya, K.; Tomioka, Y.; Yanagawa, Y.; Yoshida, H.; Adnan, S.; Hasan, M. S.; Sulaiman, H.; Gasca Lopez, G. A.; Hernandez-Cardenas, C. M.; Namendys-Silva, S. A.; Bethlehem, C.; de Lange, D.; Hunfeld, N.; Numan, S.; van Leeuwen, H.; Owens, D.; Almeida, M.; Fragoso, E.; Leonor, T.; Pereira, J. -M.; Filipescu, D.; Grigoras, I.; Popescu, M.; Tomescu, D.; Alshahrani, M. S.; Alvarez-Gonzalez, M.; Barrero-Garcia, I.; Blasco-Navalpotro, M. A.; Claverias, L.; Estella, A.; Espina, L. F.; Garmendia, J. L. G.; Prieto, E. G.; Gomez-Prieto, G.; Conde, C. J.; Sagasti, F. M.; Cantero, A. M.; Orejas-Gallego, A.; Papiol, E.; Perez-Civantos, D.; Laderas, J. C. P.; Alvarez, J. T.; Vera-Artazcoz, P.; Cortes, P. V.; Oldner, A.; Spangfors, M.; Alp, E.; Koksal, I.; Korten, V.; Ozveren, A.; Hall, A.; Hatton, K. W.; Laudanski, K.. - In: INTENSIVE CARE MEDICINE. - ISSN 0342-4642. - 46:7(2020), pp. 1404-1417. [10.1007/s00134-020-06111-5]
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study
De Bus L.;Depuydt P.;Steen J.;Dhaese S.;De Smet K.;Tabah A.;Akova M.;Cotta M. O.;De Pascale G.;Dimopoulos G.;Fujitani S.;Garnacho-Montero J.;Leone M.;Lipman J.;Ostermann M.;Paiva J. -A.;Schouten J.;Sjovall F.;Timsit J. -F.;Roberts J. A.;Zahar J. -R.;Zand F.;Zirpe K.;De Waele J. J.;Rios F.;Vazquez A. R.;Vidal M. G.;Zakalik G.;Attokaran A. G.;Banakh I.;Dey-Chatterjee S.;Ewan J.;Ferrier J.;Forbes L.;Fourie C.;Leditschke A.;Murray L.;Eller P.;Biston P.;Bracke S.;De Crop L.;De Schryver N.;Frans E.;Spapen H.;Van Malderen C.;Vansteelandt S.;Vermeiren D.;Arevalo E. P.;Crespo M.;Flores R. Z.;Piza P.;Tutillo D. M.;Elme A.;Kallaste A.;Starkopf J.;Bourenne J.;Calypso M.;Cohen Y.;Dahyot-Fizelier C.;Depret F.;Guillot M.;Imzi N.;Jochmans S.;Kouatchet A.;Lepape A.;Martin O.;Heim M.;Schaller S. J.;Arvaniti K.;Bekridelis A.;Ioannidis P.;Mitrakos C.;Papanikolaou M. N.;Pouriki S.;Vemvetsou A.;Abraham B.;Bhattacharya P. K.;Budugu A.;Dixit S.;Gurav S.;Kandanuri P.;Prabhu D. A.;Rathod D.;Savaru K.;Udupa A. N.;Varghese S. B.;Bakhodaei H. H.;Dabiri G.;Fallahi M. J.;Feiz F.;Firoozifar M.;Khaloo V.;Maghsudi B.;Masjedi M.;Nikandish R.;Sabetian G.;Marsh B.;Martin-Loeches I.;Steiner J.;Barbagallo M.;Caricato A.;Cortegiani A.;D'Andrea R.;Deana C.;Donati A.;Girardis M.;Mandala G.;Panarello G.;Pasero D.;Pelagalli L.;Soave P. M.;Spadaro S.;Fujita Y.;Fujiwara S.;Hara Y.;Hashi H.;Hashimoto S.;Hashimoto H.;Hayakawa K.;Inoue M.;Isokawa S.;Kameda S.;Kamohara H.;Kanamoto M.;Katayama S.;Kawagishi T.;Kawano Y.;Kida Y.;Kita M.;Kobayashi A.;Kuriyama A.;Naito T.;Nashiki H.;Nishiyama K.;Shindo S.;Suzuki T.;Takaba A.;Tanaka C.;Tetsuya K.;Tomioka Y.;Yanagawa Y.;Yoshida H.;Adnan S.;Hasan M. S.;Sulaiman H.;Gasca Lopez G. A.;Hernandez-Cardenas C. M.;Namendys-Silva S. A.;Bethlehem C.;de Lange D.;Hunfeld N.;Numan S.;van Leeuwen H.;Owens D.;Almeida M.;Fragoso E.;Leonor T.;Pereira J. -M.;Filipescu D.;Grigoras I.;Popescu M.;Tomescu D.;Alshahrani M. S.;Alvarez-Gonzalez M.;Barrero-Garcia I.;Blasco-Navalpotro M. A.;Claverias L.;Estella A.;Espina L. F.;Garmendia J. L. G.;Prieto E. G.;Gomez-Prieto G.;Conde C. J.;Sagasti F. M.;Cantero A. M.;Orejas-Gallego A.;Papiol E.;Perez-Civantos D.;Laderas J. C. P.;Alvarez J. T.;Vera-Artazcoz P.;Cortes P. V.;Oldner A.;Spangfors M.;Alp E.;Koksal I.;Korten V.;Ozveren A.;Hall A.;Hatton K. W.;Laudanski K.
2020
Abstract
Purpose: The DIANA study aimed to evaluate how often antimicrobial de-escalation (ADE) of empirical treatment is performed in the intensive care unit (ICU) and to estimate the effect of ADE on clinical cure on day 7 following treatment initiation. Methods: Adult ICU patients receiving empirical antimicrobial therapy for bacterial infection were studied in a prospective observational study from October 2016 until May 2018. ADE was defined as (1) discontinuation of an antimicrobial in case of empirical combination therapy or (2) replacement of an antimicrobial with the intention to narrow the antimicrobial spectrum, within the first 3 days of therapy. Inverse probability (IP) weighting was used to account for time-varying confounding when estimating the effect of ADE on clinical cure. Results: Overall, 1495 patients from 152 ICUs in 28 countries were studied. Combination therapy was prescribed in 50%, and carbapenems were prescribed in 26% of patients. Empirical therapy underwent ADE, no change and change other than ADE within the first 3 days in 16%, 63% and 22%, respectively. Unadjusted mortality at day 28 was 15.8% in the ADE cohort and 19.4% in patients with no change [p = 0.27; RR 0.83 (95% CI 0.60–1.14)]. The IP-weighted relative risk estimate for clinical cure comparing ADE with no-ADE patients (no change or change other than ADE) was 1.37 (95% CI 1.14–1.64). Conclusion: ADE was infrequently applied in critically ill-infected patients. The observational effect estimate on clinical cure suggested no deleterious impact of ADE compared to no-ADE. However, residual confounding is likely.
Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1208772
Citazioni
8
48
43
social impact
Conferma cancellazione
Sei sicuro che questo prodotto debba essere cancellato?
simulazione ASN
La simulazione può differire dall'esito di un’eventuale domanda ASN sia per errori di catalogazione e/o dati mancanti in IRIS, sia per la variabilità dei dati bibliometrici nel tempo. L’Università di Modena e Reggio Emilia non si assume alcuna responsabilità in merito all’uso che il diretto interessato o terzi faranno della simulazione.
